Clinical and functional characterisation of a novel TNFRSF1A c.605T>A/V173D cleavage site mutation associated with tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS), cardiovascular complications and excellent response to etanercept treatment

Annals of the Rheumatic Diseases
S StojanovM Schirmer

Abstract

To study the clinical outcome, treatment response, T-cell subsets and functional consequences of a novel tumour necrosis factor (TNF) receptor type 1 (TNFRSF1A) mutation affecting the receptor cleavage site. Patients with symptoms suggestive of tumour necrosis factor receptor-associated periodic syndrome (TRAPS) and 22 healthy controls (HC) were screened for mutations in the TNFRSF1A gene. Soluble TNFRSF1A and inflammatory cytokines were measured by ELISAs. TNFRSF1A shedding was examined by stimulation of peripheral blood mononuclear cells (PBMCs) with phorbol 12-myristate 13-acetate followed by flow cytometric analysis (FACS). Apoptosis of PBMCs was studied by stimulation with TNFalpha in the presence of cycloheximide and annexin V staining. T cell phenotypes were monitored by FACS. TNFRSF1A sequencing disclosed a novel V173D/p.Val202Asp substitution encoded by exon 6 in one family, the c.194-14G>A splice variant in another and the R92Q/p.Arg121Gln substitution in two families. Cardiovascular complications (lethal heart attack and peripheral arterial thrombosis) developed in two V173D patients. Subsequent etanercept treatment of the V173D carriers was highly effective over an 18-month follow-up period. Serum TNFRSF1A levels di...Continue Reading

Citations

Mar 24, 2009·Annual Review of Immunology·Seth L MastersDaniel L Kastner
Apr 27, 2011·The Journal of Clinical Investigation·Laura A Dada, Jacob I Sznajder
Nov 20, 2013·Nature Reviews. Rheumatology·Seza Ozen, Yelda Bilginer
May 17, 2014·Rheumatology·Ricardo A G Russo, Paul A Brogan
Dec 2, 2015·Seminars in Immunopathology·Alexander A NavariniLars E French
Feb 3, 2011·Annals of Medicine·Tom PetterssonHeikki Repo
Feb 24, 2015·Annual Review of Immunology·Adriana Almeida de JesusRaphaela Goldbach-Mansky
Aug 24, 2013·Mediators of Inflammation·Antonio VitaleLuca Cantarini
Nov 28, 2013·International Journal of Rheumatology·Francesco CasoLuca Cantarini
Aug 19, 2014·Mediators of Inflammation·Donato RiganteLuca Cantarini
May 5, 2009·Nature Reviews. Rheumatology·Hal M Hoffman, Anna Simon
May 15, 2015·Thrombosis Journal·Micaela La ReginaRaffaele Manna
Jul 26, 2012·Nature Reviews. Immunology·Heiyoung ParkRichard M Siegel
Jun 18, 2014·Clinical Rheumatology·Donato RiganteLuca Cantarini
Jun 26, 2015·Annals of the Rheumatic Diseases·Nienke M ter HaarJasmin B Kuemmerle-Deschner
Nov 5, 2016·Annals of the Rheumatic Diseases·Nienke M Ter HaarJoost Frenkel
Feb 3, 2011·Annals of Medicine·Donato RiganteAntonio Brucato
Nov 2, 2011·Nihon Rinshō Men'eki Gakkai kaishi = Japanese journal of clinical immunology·Hiroshi TsukamotoTakahiko Horiuchi
Sep 25, 2017·Rheumatology International·Sharika Gopakumar Menon, Petros Efthimiou
May 10, 2020·International Journal of Molecular Sciences·Cornelia CudriciIvona Aksentijevich
Nov 3, 2017·Rheumatology International·Rainer HintenbergerHerwig Pieringer
Feb 21, 2021·Autoimmunity Reviews·Albrecht BetrainsSteven Vanderschueren

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.